Patent · US Expired

Combined methods and compositions for tumor vasculature targeting and tumor treatment

US7112317B2 · kind B2 · utility

41Cited by
62References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2003
Grant dateSep 26, 2006
Priority date
Expiry dateFeb 27, 2023

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/828
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates generally to methods and compositions for targeting the vasculature of solid tumors using immunological- and growth factor-based reagents. In particular aspects, antibodies carrying diagnostic or therapeutic agents are targeted to the vasculature of solid tumor masses through recognition of tumor vasculature-associated antigens, such as, for example, through endoglin binding, or through the specific induction of endothelial cell surface antigens on vascular endothelial cells in solid tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.